Cargando…

The Impact of Genetically Proxied AMPK Activation, the Target of Metformin, on Functional Outcome Following Ischemic Stroke

BACKGROUND AND PURPOSE: We performed a two-sample Mendelian randomization (MR) analysis to evaluate the causal effect of genetically proxied AMP-activated protein kinase (AMPK) activation, which is the target of metformin, on functional outcome following ischemic stroke onset. METHODS: A total of 44...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Mengmeng, Zhang, Zhizhong, Georgakis, Marios K., Karhunen, Ville, Liu, Dandan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Stroke Society 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250876/ https://www.ncbi.nlm.nih.gov/pubmed/37282373 http://dx.doi.org/10.5853/jos.2022.03230

Ejemplares similares

Genetically proxied HTRA1 protease activity and circulating levels independently predict risk of ischemic stroke and coronary artery disease
por: Dichgans, Martin, et al.
Publicado: (2023)

Genetically Predicted Midlife Blood Pressure and Coronary Artery Disease Risk: Mendelian Randomization Analysis
por: Gill, Dipender, et al.
Publicado: (2020)

AMPK: Potential Therapeutic Target for Ischemic Stroke
por: Jiang, Shuai, et al.
Publicado: (2018)

Genetic variation supports a causal role for valproate in prevention of ischemic stroke
por: Mayerhofer, Ernst, et al.
Publicado: (2023)

Genetically proxied antidiabetic drugs targets and stroke risk
por: Zhu, Yahui, et al.
Publicado: (2023)

Interleukin-6 Signaling Effects on Ischemic Stroke and Other Cardiovascular Outcomes: A Mendelian Randomization Study
por: Georgakis, Marios K., et al.
Publicado: (2020)

Dose–response relationship between genetically proxied average blood glucose levels and incident coronary heart disease in individuals without diabetes mellitus
por: Burgess, Stephen, et al.
Publicado: (2021)

Ginkgolide B Protects Against Ischemic Stroke via Targeting AMPK/PINK1
por: Cao, Yile, et al.
Publicado: (2022)

Outcome after stroke attributable to baseline factors—The PROSpective Cohort with Incident Stroke (PROSCIS)
por: Malsch, Carolin, et al.
Publicado: (2018)

Diabetes: Chronic Metformin Treatment and Outcome Following Acute Stroke
por: Akhtar, Naveed, et al.
Publicado: (2022)

Genetically Predicted Blood Pressure Across the Lifespan: Differential Effects of Mean and Pulse Pressure on Stroke Risk
por: Georgakis, Marios K., et al.
Publicado: (2020)

Genetic Liability to Depression and Risk of Coronary Artery Disease, Myocardial Infarction, and Other Cardiovascular Outcomes
por: Lu, Yunlong, et al.
Publicado: (2020)

Metabolic regulation by the intestinal metformin-AMPK axis
por: Zhang, Song-Yang, et al.
Publicado: (2022)

Low-dose metformin targets the lysosomal AMPK pathway through PEN2
por: Ma, Teng, et al.
Publicado: (2022)

The Metformin Mechanism on Gluconeogenesis and AMPK Activation: The Metabolite Perspective
por: Agius, Loranne, et al.
Publicado: (2020)

Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
por: Singh, Manrose, et al.
Publicado: (2022)

Modifiable Lifestyle Factors and Risk of Stroke: A Mendelian Randomization Analysis
por: Harshfield, Eric L., et al.
Publicado: (2021)

Genetically determined blood pressure, antihypertensive drug classes, and risk of stroke subtypes
por: Georgakis, Marios K., et al.
Publicado: (2020)

Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation
por: Groenendijk, Floris H, et al.
Publicado: (2015)

Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK
por: Wang, Yu, et al.
Publicado: (2019)

Metformin regulates myoblast differentiation through an AMPK-dependent mechanism
por: Maniscalco, Eleonora, et al.
Publicado: (2023)

“Placebo by Proxy” and “Nocebo by Proxy” in Children: A Review of Parents' Role in Treatment Outcomes
por: Czerniak, Efrat, et al.
Publicado: (2020)

Metformin alleviates oxidative stress‐induced senescence of human lens epithelial cells via AMPK activation and autophagic flux restoration
por: Chen, Mengmeng, et al.
Publicado: (2021)

Genetically Determined Platelet Count and Risk of Cardiovascular Disease: Mendelian Randomization Study
por: Gill, Dipender, et al.
Publicado: (2018)

Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms
por: Chen, Suet Ching, et al.
Publicado: (2017)

Roseburia Abundance Associates With Severity, Evolution and Outcome of Acute Ischemic Stroke
por: Gu, Mengmeng, et al.
Publicado: (2021)

Proxy
por: Kirschner, Emilie
Publicado: (2012)

Additive Effects of Genetic Interleukin‐6 Signaling Downregulation and Low‐Density Lipoprotein Cholesterol Lowering on Cardiovascular Disease: A 2×2 Factorial Mendelian Randomization Analysis
por: Georgakis, Marios K., et al.
Publicado: (2021)

Lack of Statin Therapy and Outcomes After Ischemic Stroke: A Population-Based Study
por: Åivo, Julia, et al.
Publicado: (2023)

Metformin enhances the chemosensitivity of hepatocarcinoma cells to cisplatin through AMPK pathway
por: Dong, Hao, et al.
Publicado: (2017)

Activation of AMPK by metformin improves withdrawal signs precipitated by nicotine withdrawal
por: Brynildsen, Julia K., et al.
Publicado: (2018)

Metformin inhibits ALK1-mediated angiogenesis via activation of AMPK
por: Ying, Ying, et al.
Publicado: (2017)

Metformin limits osteoarthritis development and progression through activation of AMPK signalling
por: Li, Jun, et al.
Publicado: (2020)

Metformin attenuates diabetic renal injury via the AMPK-autophagy axis
por: Sun, Tingli, et al.
Publicado: (2021)

Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
por: Cheng, Demin, et al.
Publicado: (2021)

Astrocyte-derived exosomal nicotinamide phosphoribosyltransferase (Nampt) ameliorates ischemic stroke injury by targeting AMPK/mTOR signaling to induce autophagy
por: Deng, Yang, et al.
Publicado: (2022)

Targeting the HIV-infected brain to improve ischemic stroke outcome
por: Bertrand, Luc, et al.
Publicado: (2019)

Targeting Parthanatos in Ischemic Stroke
por: Koehler, Raymond C., et al.
Publicado: (2021)

Use of Metformin Alone Is Not Associated with Survival Outcomes of Colorectal Cancer Cell but AMPK Activator AICAR Sensitizes Anticancer Effect of 5-Fluorouracil through AMPK Activation
por: Sui, Xinbing, et al.
Publicado: (2014)

Metformin and glucose starvation decrease the migratory ability of hepatocellular carcinoma cells: targeting AMPK activation to control migration
por: Ferretti, Anabela C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qh7u2bv54iitse1vusda5ja4q9